Skip to main content
. 2017 Dec 1;10(12):11603–11609.

Figure 4.

Figure 4

Kaplan-Meier curves with univariate analyses (log-rank) for patients with low FAT2 expression versus high FAT2 expression tumors in stage III. The cumulative 5-y survival rate was 23.3% in the low FAT2 protein expression group but was only 14.3% in the high expression group (P < 0.01).